Thank you for claiming your business. Kindly check your Email for verification mail from Sulekha.com Our team will contact you shortly!.
About Relypsa
Relypsa, Inc., a Vifor Pharma Group company, is a bio pharmaceutical company focused on the development and commercialisation of late-stage medicines in the iron deficiency, nephrology and cardio-renal therapeutic areas. Relypsa is committed to delivering innovative therapies and improving the lives of patients with serious and life-threatening conditions that are often overlooked and undertreated. The Company's first medicine was approved by the U.S. FDA in 2015, making it the first approved medicine for the treatment of hyperglycemia in more than 50 years